Social Good Ecosystem is connected with the virtual currency SocialGood and all individuals and companies
VLP Therapeutics, LLC, founded in 2012 by experienced biopharmaceutical professionals, is dedicated to developing innovative medical treatments that enhance traditional vaccine and targeted antibody therapies. Headquartered in Gaithersburg, Maryland, the company focuses on addressing global unmet medical needs through its next-generation inserted alpha VLP (i-αVLP) technology. This approach aims to combat significant public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders.
VividQ Limited is a deep tech software company based in Cambridge, United Kingdom, specializing in 3D holography. Founded in February 2017 by a team of Ph.D. graduates, VividQ has developed a comprehensive software platform that enables the generation, compression, and transmission of 3D holographic images and video using standard computing power. Its key products include VividQ Capture, which standardizes 3D data for holographic display; VividQ Squeeze, a solution for compressing point cloud data; and VividQ Core, which facilitates multi-user interactions with holograms. The company also offers VividQ View, an API for integrating spatial light modulators into its holographic systems. VividQ's technology is applicable in a variety of fields, including augmented reality, virtual reality, automotive displays, and consumer electronics. By collaborating with chipmakers and manufacturers, VividQ aims to make holography a commercially viable display solution.
Startbahn, Inc. is a Tokyo-based company founded in 2014 that operates a platform focused on enhancing the art experience in the digital age. The company primarily aims to support artists and those involved in the art sector by providing essential technology and services. Startbahn develops Startbahn Cert., a service that issues blockchain certificates for artworks, and promotes Startrail, a blockchain infrastructure that underpins this certification. In addition to its blockchain initiatives, Startbahn is involved in artwork production, art direction, general planning and consulting, as well as information processing for various digital platforms. The company also offers design services for shops and offices, construction management, and print design, contributing to a more connected and innovative art community.
VLP Therapeutics, LLC, founded in 2012 by experienced biopharmaceutical professionals, is dedicated to developing innovative medical treatments that enhance traditional vaccine and targeted antibody therapies. Headquartered in Gaithersburg, Maryland, the company focuses on addressing global unmet medical needs through its next-generation inserted alpha VLP (i-αVLP) technology. This approach aims to combat significant public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders.
Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.
Floadia Corporation, established in 2011 and headquartered in Tokyo, Japan, specializes in the development, licensing, and sale of semiconductor intellectual property, with a particular focus on embedded non-volatile memory solutions. The company leverages its engineering team's extensive experience, which includes a background at Renesas, to innovate in embedded FLASH technology. Floadia's expertise encompasses the foundational technology behind widely used FLASH architecture, specifically the "Source Side Injection" method for Split Gate FLASH. In addition to its product offerings, Floadia also provides technology consulting services to support its clients in the semiconductor industry.
Varinos Inc. is a clinical testing company based in Tokyo, Japan, specializing in genomic testing and continuous clinical sequencing services. Founded in 2017, Varinos collaborates with medical institutions to offer advanced contract analysis services, utilizing next-generation sequencing technology. The company's services include testing for the endometrial microbiome and the flow of intrauterine flora, which aid in the examination and diagnosis of genetic abnormalities in embryos. By detecting microscopic amounts of bacteria and analyzing genes and chromosomes, Varinos aims to reduce the physical and mental burdens on women seeking to understand their reproductive health.
CellAxia Inc. engages in development of cell therapy drugs. The company was founded in 2017 and is based in Tokyo, Japan.
Liberaware Co., Ltd. is a Japanese company that specializes in the development and rental of industrial drones. Founded in 2016 and based in Chiba-shi, the company focuses on managing and analyzing images and flight logs collected by these drones. In addition to its core offerings, Liberaware also develops compact drones designed for maneuvering and pilot training. The company incorporates machine learning and artificial intelligence technologies to enhance its services and products.
BizteX, Inc. is a software company based in Tokyo, Japan, specializing in cloud-based robotic process automation (RPA) solutions. Founded in 2015, the company develops software designed to automate routine operations through its flagship product, BizteX Cobit. This digital robot utilizes artificial intelligence to execute repetitive tasks, allowing businesses to streamline their operations and focus on more creative and strategic activities. By offering its services globally, BizteX aims to enhance productivity and efficiency for various organizations, enabling them to optimize their resources effectively.
Goryo Chemical, Inc. specializes in the development of fluorescent probes and dyes used in chemical biology and biological applications. The company offers a range of products, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and the IndoCyanine green dye series, alongside bioluminescent probes and custom synthesis services. These products are designed for cellular analysis, assay, and imaging, and can selectively stain acidic organelles such as lysosomes and late endosomes, aiding in the detection of acidic environments. Goryo Chemical provides its products through a network of distributors both in Japan and internationally. Founded in 2010 and headquartered in Sapporo, Japan, with an additional office in Tokyo, the company is recognized as the sole manufacturer of fluorescent dyes in Japan.
Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, particularly through its innovative microwave mammography system. This technology effectively addresses the challenges associated with scattering microwaves in high-density breasts, producing clear images that assist healthcare professionals in accurately distinguishing between cancerous and normal tissue. By providing a more reliable imaging solution, Integral Geometry Science aims to reduce unnecessary pain and radiation exposure for patients compared to traditional screening methods. Additionally, the company manufactures a nondestructive inspection system specifically for lithium-ion batteries.
Atomis Inc. is a Kyoto-based company that specializes in the manufacturing of porous coordination polymers (PCPs), also known as metal-organic frameworks (MOFs). Founded in 2015, the company develops and evaluates these materials for various applications, including molecular separations, gas transportation, and high-density storage. Atomis also focuses on research and development to optimize manufacturing processes and create innovative solutions using PCPs. The company's technology is rooted in research by Distinguished Professor Susumu Kitagawa at Kyoto University. Through its work, Atomis aims to support energy companies and environmental organizations by facilitating distributed gas delivery services and carbon dioxide electro-reduction systems.
Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, particularly through its innovative microwave mammography system. This technology effectively addresses the challenges associated with scattering microwaves in high-density breasts, producing clear images that assist healthcare professionals in accurately distinguishing between cancerous and normal tissue. By providing a more reliable imaging solution, Integral Geometry Science aims to reduce unnecessary pain and radiation exposure for patients compared to traditional screening methods. Additionally, the company manufactures a nondestructive inspection system specifically for lithium-ion batteries.
StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006. The company specializes in the development of regeneration-guided medicines aimed at treating challenging diseases such as epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM's innovative approach involves mobilizing the body's own stem cells to target injured or diseased tissues without the need for extraction. Their product portfolio includes PJ1 regeneration induction medicine using HMGB1 peptides, PJ2 and PJ3 regeneration-inducing drugs and proteins, as well as the PJ4 therapeutic autologous cell collection device and PJ5 stem cell gene therapy technology. Through its research and development efforts, StemRIM seeks to advance the field of regenerative medicine and provide effective treatment options for patients with intractable conditions.
Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.
ARTham Therapeutics Inc is a biopharmaceutical company based in Naka-Ku, Japan, founded in 2018. The company focuses on developing innovative drugs and therapies aimed at treating debilitating diseases, particularly inflammatory skin conditions, vascular malformations, and endometriosis in the context of immuno-oncology. Its product pipeline includes programs such as art-648, art-ep, art-pde, and art-001, which are designed to address specific medical needs, facilitating faster recovery and improving the quality of life for patients.
Trigence Semiconductor, Inc. operates as an audio IC design and solution provider. The company offers digital audio products, such as Digital Speaker Module that include speakers, enclosures, connectors, FPCs, audio DSPs, and interfaces to simplify development for PC, tablet, and smartphone required audio functionality; and digital speaker drivers, USBs, and evaluation boards for the consumer and IT markets. It provides products for applications in computer and laptop, headsets, sound-bar, and Bluetooth speaker. The company offers its products through distributors. Trigence Semiconductor, Inc. was founded in 2006 and is based in Tokyo, Japan with offices in Japan, the United States, Hong Kong, and Taiwan.
Megakaryon Corporation develops platelets and red blood cells from human iPS cell lines. Its portfolio includes blood products that do not depend on blood donations. The company was founded in 2011 and is based in Kyoto, Japan with an additional office in Tokyo, Japan.
StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006. The company specializes in the development of regeneration-guided medicines aimed at treating challenging diseases such as epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM's innovative approach involves mobilizing the body's own stem cells to target injured or diseased tissues without the need for extraction. Their product portfolio includes PJ1 regeneration induction medicine using HMGB1 peptides, PJ2 and PJ3 regeneration-inducing drugs and proteins, as well as the PJ4 therapeutic autologous cell collection device and PJ5 stem cell gene therapy technology. Through its research and development efforts, StemRIM seeks to advance the field of regenerative medicine and provide effective treatment options for patients with intractable conditions.
Institution for a Global Society is a a French graduate school with students from 70 countries around the world
REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.
Drivemode, Inc. is a technology company that specializes in enhancing the driving experience through its mobile-based connected car platform. Founded in 2014 by former entrepreneurs from Zipcar and Tesla Motors, Drivemode's application integrates driving patterns, calendar events, and recent communications to provide navigation suggestions and facilitate seamless control of music applications. The platform features voice-to-text messaging, an intuitive interface, and large buttons, allowing drivers to manage smartphone functions such as navigation and calls using voice commands. This technology aims to minimize distractions while driving, promoting safer and smarter driving practices. Since its launch in 2015, the Drivemode app has gained significant traction, amassing over one million downloads across more than 180 countries. Drivemode operates as a subsidiary of Honda R&D Co., Ltd., further solidifying its position in the connected car ecosystem. The company continues to collaborate with various automakers and industry stakeholders to advance its innovative solutions for drivers.
FLOSFIA INC. is a Tokyo-based company that specializes in the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the firm emerged as a spin-off from research conducted at Kyoto University. FLOSFIA focuses on utilizing the unique physical properties of gallium oxide to create low-loss power devices that offer high breakdown voltage and efficiency. The company employs mist chemical vapor deposition (CVD) techniques for film formation, which enhances the performance of its semiconductor products.
Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.
Kyoto Drug Discovery and Development Co. Ltd., based in Kyoto, Japan, specializes in the development of therapeutic drugs aimed at treating chronic degenerative eye diseases. The company focuses on innovative agents for conditions such as glaucoma, central retinal artery occlusion (CRAO), retinitis pigmentosa, and age-related macular degeneration (AMD), which are often considered incurable or intractable. By creating effective treatments for these serious conditions, Kyoto Drug Discovery and Development enables healthcare professionals to better diagnose and manage patients suffering from these debilitating eye diseases.
Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, particularly through its innovative microwave mammography system. This technology effectively addresses the challenges associated with scattering microwaves in high-density breasts, producing clear images that assist healthcare professionals in accurately distinguishing between cancerous and normal tissue. By providing a more reliable imaging solution, Integral Geometry Science aims to reduce unnecessary pain and radiation exposure for patients compared to traditional screening methods. Additionally, the company manufactures a nondestructive inspection system specifically for lithium-ion batteries.
AFI Japan is a manufacturer based in Osaka that specializes in cell measuring equipment and inspection technologies. The company develops and sells products aimed at the food and life sciences industries, including electric filter separation technology and rapid detection systems for monitoring microbial contamination risks. By providing these advanced technologies, AFI Japan enables its clients to enhance food safety and respond effectively to various microbiological testing needs.
Farmship, Inc., founded in 2014 and based in Tokyo, Japan, specializes in agricultural food distribution and vertical farming technology. The company employs artificial intelligence and data analytics to optimize growing conditions in vertical farms, promoting sustainable and efficient food production. By leveraging this innovative approach, Farmship aims to enhance crop yields while minimizing resource usage and reducing the environmental impact of agriculture. This commitment to sustainability positions Farmship as a key player in the future of food production.
Megakaryon Corporation develops platelets and red blood cells from human iPS cell lines. Its portfolio includes blood products that do not depend on blood donations. The company was founded in 2011 and is based in Kyoto, Japan with an additional office in Tokyo, Japan.
Nota, Inc. is a technology company that develops and provides a collaborative web platform designed for creating, sharing, and collaborating on presentations and various forms of online content. It offers Nota for Education, a tool aimed at students and educators to facilitate the creation and sharing of documents such as presentations, notebooks, and reports. Nota is also known for Gyazo, a popular cloud-based screen capture and sharing application that allows users to easily share screenshots via custom URLs. With a user base exceeding 8 million, Gyazo has experienced significant growth through viral acquisition strategies. Founded in 2007, Nota operates from Menlo Park, California, and has additional offices in Kyoto and Tokyo, Japan, reflecting its ambition to blend global outreach with its Japanese roots.
iHeart Japan Corporation is focused on developing innovative regenerative medicinal products aimed at treating severe heart failure, with the goal of reducing the reliance on heart transplantation. The company leverages induced pluripotent stem cell (iPSC) technology, originally developed by researchers at Kyoto University, to create a cell sheet that can be attached to the heart. This process promotes the formation of a vascular network, enhancing blood circulation and therapeutic outcomes for patients. In addition to its primary product development, iHeart Japan also offers healthcare consulting and contract services, supporting physicians in their efforts to restore cardiac function and address conditions related to other organs, such as the liver.
MONEY DESIGN Co., Ltd. offers asset management and investment advice services. The company was founded in 2013 and is based in Tokyo, Japan.